ARK Genomic Revolution ETF (BATS:ARKG) Hits New 1-Year High – Here’s What Happened

ARK Genomic Revolution ETF (BATS:ARKG)’s stock price reached a new 52-week high on Tuesday . The company traded as high as $49.96 and last traded at $49.85, with a volume of 1372721 shares traded. The stock had previously closed at $48.01.

ARK Genomic Revolution ETF Price Performance

The company’s 50 day moving average is $41.10 and its 200-day moving average is $33.54.

Hedge Funds Weigh In On ARK Genomic Revolution ETF

Several large investors have recently made changes to their positions in ARKG. Turner Financial Group Inc. bought a new position in ARK Genomic Revolution ETF during the 2nd quarter valued at approximately $1,633,000. Continuum Advisory LLC purchased a new stake in shares of ARK Genomic Revolution ETF in the second quarter worth $76,000. MBA Advisors LLC purchased a new stake in shares of ARK Genomic Revolution ETF in the second quarter worth $270,000. SkyOak Wealth LLC bought a new position in shares of ARK Genomic Revolution ETF during the second quarter valued at $213,000. Finally, Beacon Financial Advisory LLC bought a new position in shares of ARK Genomic Revolution ETF during the second quarter valued at $245,000.

About ARK Genomic Revolution ETF

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.